Skip to main content
logo
Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
28.98
-2.29 (-7.32%)
Oct 1, 2026, 4:00 PM EDT - Market closed

Structure Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,0674,8091,5531,991--
Market Cap Growth
41.81%209.65%-22.02%---
Enterprise Value
7304,0176421,790--
Last Close Price
31.2769.5527.1240.76--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.643.171.804.40--
P/TBV Ratio
1.583.171.804.40--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.000.010.000.01
Net Debt / Equity Ratio
-0.99-0.95-1.02-1.02-1.07-1.04
Net Debt / EBITDA Ratio
5.037.785.604.511.732.84
Net Debt / FCF Ratio
5.956.387.465.661.963.20
Quick Ratio
20.3124.4324.5318.896.9812.39
Current Ratio
20.7524.8124.7419.147.1612.62
Return on Equity (ROE)
-20.21%-11.86%-18.59%-33.33%-54.87%-55.24%
Return on Assets (ROA)
-14.95%-9.39%-14.28%-22.16%-31.44%-31.44%
Return on Capital Employed (ROCE)
-19.70%-12.30%-18.20%-22.50%-62.00%-36.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.05%-2.94%-7.89%-4.50%--
FCF Yield
-10.50%-4.70%-7.59%-4.10%--
Buyback Yield / Dilution
-16.34%-12.46%-43.31%-1049.81%-17.72%-30.01%
SEC Filings: 10-K · 10-Q